Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01005927 · ClinicalTrials.gov registry record · Phase 1
Fructooligosaccharide and Calcium Absorption in Adolescent Girls
A Phase 1 study, sponsored by Purdue University.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT01005927 is a Phase 1 study that has completed, run by Purdue University. The registered enrollment target is 26 participants.
The verdict
NCT01005927, a Phase 1 study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
Fructooligosaccharides (FOS) are believed to have positive effects on calcium absorption and bone accrual during growth. This study aims to see whether the addition of fiber in the form of FOS to a calcium-containing beverage will increase calcium absorption. During two clinical visits, participants will receive a beverage containing a small amount of calcium, supplemented with either no dietary fiber or a small amount of fiber. Height, weight, bone density and geometry, calcium absorption, and physical fitness will be measured. The effects of this fiber intervention may provide support for improving bone health with minimal fiber supplementation.
Interventions
- DIETARY_SUPPLEMENT Fructooligosaccharide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01005927
The ClinicalTrials.gov registry entry for NCT01005927 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fructooligosaccharide is the first listed.
NCT01005927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01005927 about?
NCT01005927 is a clinical study titled "Fructooligosaccharide and Calcium Absorption in Adolescent Girls". Fructooligosaccharides (FOS) are believed to have positive effects on calcium absorption and bone accrual during growth. This study aims to see whether the addition of fiber in the form of FOS to a calcium-containing beverage will increase calcium absorption. During two clinical visits, participants...
What is the current status of trial NCT01005927?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2009-01. Estimated completion is 2009-06.
What interventions are being tested in trial NCT01005927?
The interventions under investigation include: Fructooligosaccharide (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01005927?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.